SUPPLEMENT

Q3 2020 — Condensed Consolidated Statement of Earnings

Q3 2020PDF · 2 pages28 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	21,082	$ 	100.0 	20,729	$ 	100.0 	1.7
Cost of products sold 	6,972 	33.1 	6,867 	33.1 	1.5
Gross Profit 	14,110 	66.9 	13,862 	66.9 	1.8
Selling, marketing and administrative expenses 	5,431 	25.8 	5,374 	26.0 	1.1
Research and development expense 	2,840 	13.5 	2,599 	12.5 	9.3
In-process research and development 	138 	0.6 	- 	-
Interest (income) expense, net 	32 	0.1 	(41) 	(0.2)
Other (income) expense, net 	1,200 	5.7 	4,214 	20.3
Restructuring 	68 	0.3 	69 	0.4
Earnings before provision for taxes on income 	4,401 	20.9 	1,647 	7.9 	167.2
Provision for/(Benefit from) taxes on income 	847 	4.0 	(106) 	(0.6)
Net earnings 	3,554	$ 	16.9 	1,753	$ 	8.5 	102.7
Net earnings per share (Diluted) 	1.33	$ 	0.66	$ 	101.5
Average shares outstanding (Diluted) 	2,669.3 	2,669.9
Effective tax rate 	19.2 % 	(6.4) %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	7,246	$ 	34.4 	7,116	$ 	34.3 	1.8
Net earnings 	5,868	$ 	27.8 	5,672	$ 	27.4 	3.5
Net earnings per share (Diluted) 	2.20	$ 	2.12	$ 	3.8
Effective tax rate 	19.0 % 	20.3 %
(1) See Reconciliation of Non-GAAP Financial Measures.
THIRD QUARTER
2020 	2019

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	60,109	$ 	100.0 	61,312	$ 	100.0 	(2.0)
Cost of products sold 	20,613 	34.3 	20,422 	33.3 	0.9
Gross Profit 	39,496 	65.7 	40,890 	66.7 	(3.4)
Selling, marketing and administrative expenses 	15,627 	26.0 	16,139 	26.3 	(3.2)
Research and development expense 	8,127 	13.5 	8,123 	13.3 	0.0
In-process research and development 	144 	0.3 	890 	1.4
Interest (income) expense, net 	16 	0.0 	(43) 	(0.1)
Other (income) expense, net 	545 	0.9 	2,509 	4.1
Restructuring 	187 	0.3 	162 	0.3
Earnings before provision for taxes on income 	14,850 	24.7 	13,110 	21.4 	13.3
Provision for taxes on income 	1,874 	3.1 	2,001 	3.3 	(6.3)
Net earnings 	12,976	$ 	21.6 	11,109	$ 	18.1 	16.8
Net earnings per share (Diluted) 	4.86	$ 	4.13	$ 	17.7
Average shares outstanding (Diluted) 	2,670.8 	2,688.1
Effective tax rate 	12.6 % 	15.3 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	19,827	$ 	33.0 	22,597	$ 	36.9 	(12.3)
Net earnings 	16,468	$ 	27.4 	18,283	$ 	29.8 	(9.9)
Net earnings per share (Diluted) 	6.17	$ 	6.80	$ 	(9.3)
Effective tax rate 	16.9 % 	19.1 %
(1) See Reconciliation of Non-GAAP Financial Measures.
NINE MONTHS
2020 	2019

-- 2 of 2 --